menu
    • menu

    Company profile for Alfasigma

    NEW Drugs in Dev: 8
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alfasigma is one of the top 5 pharmaceutical companies in Italy, with a turnover in 2019 of more than 1 billion euros. It’s a private company with 75% owned by the family of the founder and 25% by two funds. The Alfasigma legacy is firmly anchored in a long lasting heritage of innovation and success, beginning in 1948 in Bologna (Italy) thanks to Marino Golinelli, the 100 years old philanthropist. From the beginning Alfasigm...
    Alfasigma is one of the top 5 pharmaceutical companies in Italy, with a turnover in 2019 of more than 1 billion euros. It’s a private company with 75% owned by the family of the founder and 25% by two funds. The Alfasigma legacy is firmly anchored in a long lasting heritage of innovation and success, beginning in 1948 in Bologna (Italy) thanks to Marino Golinelli, the 100 years old philanthropist. From the beginning Alfasigma has always pursued a twofold strategy: – internally, a strong focus on Research & Development and Manufacturing around some proprietary molecules, some of which represent more than 50% of the sales.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AlfasigmaItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Bologna - Via Ragazzi del ‘99, 5
    Telephone
    Telephone
    +39 0516489511
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alfasigma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alfasigma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alfasigma Reports 2025 Growth Led By Immunology Gastro Vascular
    Alfasigma Reports 2025 Growth Led By Immunology Gastro Vascular

    31 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260330615597/en/Alfasigma-Reports-Solid-Performance-in-2025-Supported-by-Double-Digit-Revenue-Growth-in-key-strategic-brands-in-Immunology-171-Gastroenterology-15-Vascular-10-and-Consumer-Healthcare-expansion-portfolio-in-international-markets

    BUSINESSWIRE
    31 Mar 2026
    Share Share
    After Alfasigma licensing deal, Lynavoy picks up FDA nod
    After Alfasigma licensing deal, Lynavoy picks up FDA nod

    19 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/alfasigmas-690m-gsk-buy-lynavoy-widens-pbc-space-fda-approval-rare-liver-disease

    FIERCE PHARMA
    19 Mar 2026
    Share Share
    Alfasigma's $690M Deal For GSK Itch Drug Awaiting FDA Decision
    Alfasigma's $690M Deal For GSK Itch Drug Awaiting FDA Decision

    09 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/alfasigma-pens-690m-deal-gsk-itching-drug-awaiting-fda-approval-decision

    FIERCE BIOTECH
    09 Mar 2026
    Share Share
    Alfasigma Pens €125M Deal For Injectable Form Of HSV Treatment
    Alfasigma Pens €125M Deal For Injectable Form Of HSV Treatment

    15 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/italys-alfasigma-pens-eu125m-deal-injectable-form-german-biotechs-hsv-treatment

    FIERCE BIOTECH
    15 Jan 2026
    Share Share
    Alfasigma Acquires Exclusive Rights To Parenteral Adibelivir
    Alfasigma Acquires Exclusive Rights To Parenteral Adibelivir

    13 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-13/alfasigma-secures-exclusive-rights-from-innovative-molecules-to-parenteral-adibelivir-for-treatment-of-hsv-encephalitis-an-ultra-rare-disease

    PHARMIWEB
    13 Jan 2026
    Share Share
    Intercept Withdraws Ocaliva for PBC from US Market, Trial on Hold
    Intercept Withdraws Ocaliva for PBC from US Market, Trial on Hold

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148535/23024/en/Intercept-Announces-Voluntary-Withdrawal-of-OCALIVA-for-Primary-Biliary-Cholangitis-PBC-from-the-US-Market-US-Clinical-Trials-Involving-Obeticholic-Acid-Placed-on-Clinical-Hold.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Alfa Wassermann SPA and get a quotation

    Alfa Wassermann SPA is a supplier offers 4 products (APIs, Excipients or Intermediates).

    Find Meprobamate bulk offered by Alfa Wassermann SPA

    Find Naproxen Sodium bulk offered by Alfa Wassermann SPA

    Find Tolbutamide bulk offered by Alfa Wassermann SPA

    Find Sulodexide bulk offered by Alfa Wassermann SPA

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search